Status:
NOT_YET_RECRUITING
Comparison of Remimazolam-based MAC With Inhalation General Anesthesia Under the Guidance of an ANI Monitor During TURB
Lead Sponsor:
Yonsei University
Conditions:
Patients Undergoing Transurethral Resection of Bladder
Eligibility:
All Genders
20+ years
Phase:
NA
Brief Summary
In patients undergoing transurethral resection of bladder, the effect of remimazolam-based monitored anesthesia care (MAC) and inhalational general anesthesia will be compared under guidance by analge...
Detailed Description
In remimazolam-based MAC group, anesthesia will be induced with remimazolam and spontaneous breathing will be maintained. The dose of remimazolam and remifentanil will be adjusted according to the pat...
Eligibility Criteria
Inclusion
- patients undergoing transurethral bladder resection
Exclusion
- ASA class 4
- emergency surgery
- history of hypersensitivity to sevoflurane, propofol and remimazolam
- galactose intolerance
- patient refusal
- patients in whom muscular relaxation are needed.
Key Trial Info
Start Date :
January 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2024
Estimated Enrollment :
46 Patients enrolled
Trial Details
Trial ID
NCT06217055
Start Date
January 1 2024
End Date
October 1 2024
Last Update
January 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Yonsei university college of medicine
Seoul, South Korea